Health Kick: This stock has a clear vision for the future of contact lenses
Health & Biotech
share
Stockhead’s resident Health and Biotech expert Tim Boreham is putting down the microscope and picking up the microphone for another instalment of The Health Kick Podcast.
In this episode Tim chats with Dr Stephen Snowdy, CEO from Visioneering Technologies (ASX:VTI).
Headquartered in Alpharetta, Georgia, Visioneering holds a portfolio of technologies focused on addressing eye care issues such as presbyopia, myopia and astigmatism.
The pair discuss the company’s genesis, lead technology, the widespread under-diagnosis of eye issues and more. So click below to tune in.
On mobile? Click here to listen with Apple podcasts, here for Spotify or here for Google Podcasts.
Like to listen to podcasts through another app? Just search for The Health Kick Podcast with Tim Boreham and subscribe!
- Subscribe to our daily newsletter
- Join our small cap Facebook group
- Follow us on Facebook or Twitter
share
Featured Companies
Sponsored Articles
Trending in Health & Biotech
Featured Companies
Editors Picks
-
Bitcoin v Gold: Can the cryptocurrency steal the safe haven crown?
-
Investor view: The road ahead for ASX fintech disruptors after a big 2020
-
Dividend Stocks: Here are some of the ASX's most generous payers
-
The ASX pot stocks looking to get high on Canada's $3bn market
-
T.Rowe Price favours 'small cap and emerging market stocks' in post-Covid era
